IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Florida

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Florida $ 26,057,929.04
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
.Decimal Inc. Development and Commercialization of Electron Conformal Therapy Bolos $ 144,260.68 $ 77,112.17
Accentia Biopharmaceuticals Inc Revimmune ReBOOT for the treatment of Multiple Sclerosis $ 75,187.50 $ 169,291.75
Accu-Break Pharmaceuticals Inc and Subsidiaries Accu-Break Wafarin $ 244,479.25  
Adhaere Pharmaceuticals Inc Novel therapeutic strategies for preserving vascular access graft in hemodialysis patients   $ 45,390.00
Altor Bioscience Corporation Altor QTD Project #5 -  Development of IL-15 Superagonists for Cancer $ 1,631.65 $ 132,923.11
Altor Bioscience Corporation Altor QTD Project #2 -  Development of ALT-802 for Cancer $ 163,352.23 $ 81,127.01
Altor Bioscience Corporation Altor QTD Project #1-  Development of ALT-801 for Cancer $ 244,479.24  
Altor Bioscience Corporation Altor QTD Project #6 -  Development of DPC-1528, an Antisense Drug for Acne $ 171,144.86 $ 19,428.32
Altor Bioscience Corporation ALtor QTD Project #3 -  Development of ALT-836 for ALI/ARDS   $ 60,512.03
AOI Medical Inc Ascendx Spine Technology $ 244,479.25  
Applied Genetic Technologies Corp Alpha One Trial $ 244,479.25  
Applied Genetic Technologies Corp Achromatopsia Project $ 244,479.25  
Applied Genetic Technologies Corporation XLRS Project $ 7,446.74 $ 237,032.51
Applied Genetic Technologies Corporation LCA Trial $ 188,664.43 $ 55,814.82
Aquatrove Biosciences Inc Novel stratefies for the treatment of vaginal dryness in trying to conceive patients $ 33,506.00 $ 95,000.00
Aspiration Medical Technology LLC FoodDivurzn (FD) Weight Management System $ 244,479.24  
Atlas Spine, Inc. APELO $ 244,479.24  
Banyan Biomarkers, Inc. Biomarkers of Brain Injury: Magnitude, Secondary Insults and Outcome $ 244,479.25  
Bioheart, Inc. MARVEL Trial REGEN Trial $ 244,479.24  
Bio-Nucleonics Inc Novel Peptidomimetic for Unstable Atherosclertic Plague detection and differentiation. $ 244,479.24  
Bio-Nucleonics Inc Rubidium $ 244,479.25  
Bio-Nucleonics, Inc. Gallium-68/Germanium-68 Radionuclide Generator $ 244,479.25  
Bio-Nucleonics, Inc. Gynocyte $ 244,479.25  
Biovest International Inc. BiovaxID - a patient-specific vaccine for B-cell Non-Hodgkin's Lymphoma $ 244,479.25  
Catalyst Pharmaceutical Partners, Inc CPP-109 For The Treatment Of Stimulant Dependence $ 244,479.24  
Catalyst Pharmaceutical Partners, Inc CPP-115 for the treatment of various forms of Epilepsy and stimulant dependence $ 110,454.66 $ 134,024.58
CHS RESOURCES, LLC TOPICAL TREATMENT FOR SKIN CANCER AND OTHER PRE-CANCEROUS CONDITIONS. $ 60,442.50 $ 184,036.75
Claro Scientific, LLC SpectraWave Blood and Blood Culture Diagnostic System $ 244,479.25  
Concordia Pharmaceuticals, Inc. Salirasib $ 244,479.24  
Converge Biotech Inc Biohybrid Device for Treatment of Diabetes $ 94,570.00 $ 84,932.00
Convergent Engineering eToco Maternal Fetal Monitoring $ 25,162.00 $ 9,564.50
Convergent Engineering Inc. ID-Cap $ 28,385.50  
CORD:USE Cord Blood Bank, Inc Allogeneic Cord Blood Banking $ 244,479.25  
Cytorex Biosciences, Inc. Cytoreg® $ 244,479.25  
Dharma Biomedical, LLC Isolation and Synthesis of Bioactive Molecules from Commiphora wightii Bark Oleoresin $ 48,612.54 $ 52,025.56
Electrostim Medical Services Inc. dba EMSI Iglucotouch   $ 244,479.24
EnCor Biotechnology Inc. Development of diagnostic biomarkers of CNS damage and disease states $ 85,303.50 $ 159,175.75
Envoy Therapeutics, Inc A New Oral Therapy for Treating Cognitive Deficts Associated with Schizophrenia $ 10,827.50 $ 233,651.75
Envoy Therapeutics, Inc. A Novel, Non Dopamine-Based oral Therapy for Parkinson's Disease $ 20,437.50 $ 224,041.75
Envoy Therapeutics, Inc. An Oral Therapy for Parkinson's Disease designed to mimic Deep Brain Stimulation $ 20,437.50 $ 224,041.75
eTect LLC ID Cap $ 21,539.06 $ 173,403.94
Eyetech Inc The Macugen ER Project $ 141,639.50 $ 102,839.74
Florida Cancer Care Network, LLC Radiation Therapy Oncology management Program   $ 244,479.25
GeneEx, Inc A Rapid Point-of-Care Diagnostic for Active Periodontal Disease $ 244,479.25  
GeneEx, Inc A Rapid Point-of-Care Diagnostic for Active Group A Streptococcal Pharyngitis   $ 244,479.25
GeNO LLC A ultra-pure inhalede Nitric Oxide drug for chronic treatment of mutiple pulmonary diseases for unmet medical needs $ 244,479.24  
GlG Pharma LLC GLG-202 Manufacturing and IND-Enabling Pre-Clinical Toxicology Studies   $ 244,479.25
GLG Pharma LLC GLG-401 Manufacturing and IND-Enabling Pre-clinical Toxicology Studies   $ 244,479.25
GLG Pharma, LLC GLG-302 Manufacturing and IND-Enabling Pre-Clincal Toxicology Studies   $ 244,479.24
Heat Biologics Inc HS-System $ 82,044.68 $ 162,434.56
Imigene Inc High Clinical Relevancy Point of Care Blood Borne Bacteria Detection $ 91,800.00 $ 152,679.25
InnFocus a Novel Drug/Medical Device Treatment for Glaucoma $ 244,479.24  
Intezyne Technologies, Inc Polymer Polyplex $ 52,231.88 $ 43,059.02
Intezyne Technologies, Inc Ivect Technology $ 244,479.24  
iSense, LLC Colorimetric Breath Analyzer for Lung Cancer Diagnosis $ 156,605.83 $ 87,873.42
Ivax Diagnostics, Inc. Mago4S and diagnostic ELISA and IFA assays $ 244,479.25  
LifeSync Corporation WECGII $ 244,479.25  
LINGUAFLEX, INC LINGUAFLEX TONGUE RETRACTOR (LTR) $ 244,479.24  
Mergenet Medical, Inc HiFLO HFT with Airway Pressure Monitoring $ 200,174.50 $ 44,304.74
Metabogenix Technologies, Inc Combining inhibitors of glycolysis with cancer chemotherapy to increase treatment efficacy $ 244,479.25  
Metabogenix Technologies, Inc. Fenofibrate induces endoplasmic reticulum stress leading to selective toxicity in multiple myeloma cells $ 244,479.25  
Morphogenesis, Inc ImmuneFx ™ Cancer immunotherapy $ 161,560.50 $ 82,918.74
Nanotherapeutics Inc NanoDOX 1% Doxycycline Monohydrate Hydrogel for the treatment of Chronic Wounds $ 91,995.13 $ 98,718.24
Nanotherapeutics, Inc. NanoBUP Buprenorphine/Naloxone Capsule for the Treatment of Opiod Addiction $ 74,617.68 $ 169,861.57
Nanotherapeutics, Inc. NanoFOVIRTM Inhaled Cidofovir Dry-Powder Formulation for Postexposure $ 244,479.25  
Nanotherapeutics, Inc. NonoGENT™ Gentamicin Sulfate Inhalation Powder for post-exposure prophylaxix of pneumonic plague (Yersinia pestis) $ 244,479.25  
NeoGenomics Inc Melanoma FISH Test $ 244,479.24  
NeoGenomics Laboratories Inc Barrett's esophagus FISH Test   $ 130,000.00
Neuro Assisted Recovery Inc NTMD for treatment of Comorbid Substance abuse disorders $ 234,715.00 $ 9,764.25
Nutra Pharma Corporation Development of Recet for the treatment of pain   $ 244,479.25
Ocean Ridge Biosciences, LLC Serum MicroRNAs as Prognostic Markers of Emphysema $ 34,873.00 $ 34,562.00
OPKO Instrumentation, LLC a single member LLC of OPKO Health, Inc Aquashunt $ 244,479.25  
OPKO Pharmaceuticals LLC Rolapitant $ 244,479.25  
OPKO Pharmaceuticals LLC a single member LLC of OPKO Health, Inc Bevasiranib $ 244,479.25  
Optima Neuroscience, Inc. High Performance Automated Seizure Detection $ 244,479.25  
Oragenics Inc Novel Antibiotics for the Treatment of Healthcare Associated Infections $ 132,041.27 $ 112,437.97
Oragenics, Inc Rapid and Sensitive Id. Of Novel Diagnostic Biomarkers for Cancer for Cancer and Infectious Diseases $ 186,971.87 $ 57,507.37
Oragenics, Inc Prevention of Tooth Decay using SMaRT Replacement Therapy $ 52,206.00 $ 192,273.24
Orbus Neich Medical, Inc Combo Bio-engineered Sirolimus-eluting Stent (Combo Stent) $ 244,479.24  
OxThera, Inc Development of Oxabact(R) for the Treatment of Primary Hyperoxaluria $ 244,479.24  
ParinGenix, Inc. Prevention of heparin-induced thrombocytopenia and associated thrombosis $ 26,693.00 $ 125,648.00
ParinGenix, Inc. Development of a treatment of pediatric protein-losing enteropathy $ 19,938.50 $ 204,564.50
Pioma Inc TAME-DX: A blood based diagnostic for evidence-based treatment of brain cancer. $ 63,885.00 $ 180,594.25
Precision Medical Devices, Inc Flow Control Device $ 105,038.00 $ 139,441.25
Quantum Immunologics Inc Development of Oncofetal Antigen/immature Laminin Receptor Protein (OFA/iLRP) peptides for the treatment of cancer $ 66,922.72 $ 137,628.09
Quantum Immunologics Inc A Phase I/II Study with Autologous Dendritic Cells Loaded with Oncofetal Antigen/iL RP in Patients with Metastatic Breast Cancer $ 244,479.25  
Quantum Immunologics, Inc Developmental of Monoclonal Antibodies against OFA/ILRP $ 59,506.57 $ 137,628.09
Quick-Med Technologies, Inc NIMBUS Wound Dressings/Drain (DWD) $ 244,479.25  
SafeStitch Medical, Inc. and Subsidiaries AMID Stapler for Simplified Stapled Lichtenstein Procedure (SSLP) $ 244,479.25  
Seraph Pharmaceuticals Ketogenic diet in a pill with antioxidant activity for control of epileptic seizures $ 10,750.00 $ 35,000.00
Sinapis Pharma Inc IV Methamphetamine for Stroke and other acute ischemic conditions $ 186,112.00 $ 58,367.24
SKELETAL DYNAMICS LLC INTERNAL JOINT STABILIZER FOR THE ELBOW $ 134,395.88 $ 110,083.36
Skeletal Dynamics LLC Align Radial Head Arthroplasty System $ 152,094.98 $ 92,384.26
Syntheon LLC Milwaukee Project $ 244,479.25  
TauTaTis, Inc Evaluation of the kinase inhibitor TTT-3002 for neurodegenerative diseases and cancer $ 109,391.50 $ 135,087.74
Tele Home Care Solutions Company The Tele Home Care Solution Project   $ 152,410.83
Tigris Pharmaceuticals, Inc AFP-464 $ 244,479.25  
Tigris Pharmaceuticals, Inc. GGTI-2418 $ 244,479.25  
Tissue Tech, Inc Treatment for Demodex Infestation by Active Ingredient from Tea Tree Oil $ 31,783.50 $ 162,450.50
Tissue Tech, Inc Novel Therapeutics based on Amniotic Membrane Extract and its Purified Component $ 164,862.00 $ 79,617.25
Tissue Tech,Inc development of a Novel Device to deliver Therapeutics to Ocular Surface $ 51,019.50 $ 90,106.00
Tissuetech,Inc Novel Ex Vivo Expansion of Limbal stem Cells $ 189,002.50 $ 55,476.75
Tyrogenex Inc X-82 VEGFR/PDGFR small molecule kinase inhibitor $ 155,311.00 $ 89,168.25
Venx LLC Device Strategies for the management of Venous Stasis $ 39,549.00 $ 165,950.50
Winprobe Corporation The Ultravision Research Project $ 244,479.25  
Xcelience SKL-10406 $ 61,698.47 $ 17,564.24
Xcelience Holdings LLC PX-866 $ 39,831.05 $ 27,468.85
Xcelience Holdings LLC CTO $ 18,562.47 $ 7,738.27
Xcelience Holdings, LLC DAS-181 $ 21,073.91 $ 54,300.04
Xcelience Holdings, LLC AM-152   $ 53,076.00
Xcelience Holdings, LLC CC-930 $ 156,629.47 $ 87,849.78
Xcelience Holdings, LLC AT-406 $ 26,236.82 $ 13,418.48
Xcelience Holdings, LLC OSI-296 $ 50,273.75 $ 28,662.85
Xcelience Holdings, LLC Acuracet $ 165,781.99 $ 78,697.26
Xcelience Holdings, LLC Duodopa   $ 22,118.87
Xcelience Holdings, LLC AP24534 $ 52,264.27 $ 192,214.98
Xcelience Holdings, LLC Alpha-tocherolquinone $ 60,602.00 $ 183,877.25
Xcelience Holdings, LLC Loperamide $ 69,003.32 $ 54,202.23
Xcellience Holdings, LLC PN-3602 $ 89,974.23 $ 143,487.74
Xcovery Holding Company LLC X-379 c-Met small molecule kinase inhibitor $ 35,661.50 $ 208,817.75
Xcovery Holding Company LLC x-387 mTor (TORC1/TORC2) small molecule kinase inhibitor $ 177,961.50 $ 66,517.75
Xcovery Holding Company LLC X-396 (ALK) small molecule kinase inhibitor $ 41,638.00 $ 202,841.25
Xhale diagnostics, Inc One Breath: a non-invasive glucose self-monitoring system using exhaled breath $ 244,479.25  
Xhale, Inc. Next generation evidential breath-based ethanol sensor to diagnose and treat alcohol abuse $ 69,604.00 $ 108,888.00

 

Page Last Reviewed or Updated: 05-Jun-2014